Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
Tufts Medical Center · Edwards (United Kingdom) · +3 more institutions
Abstract
BACKGROUND: End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined. METHODS AND RESULTS: Three HCM cohorts comprised 1259 patients, including 44 (3.5%) characterized as ES with systolic dysfunction (ejection fraction
Citation impact
- FWCI
- 17.70
- Percentile
- 100%
- References
- 37
Authors
10- KMKevin M. HarrisCorresponding
Tufts Medical Center, Edwards (United Kingdom), Beth Israel Deaconess Hospital, Ente Ospedaliero Ospedali Galliera, Minneapolis Heart Institute Foundation
- PSPaolo Spirito
Tufts Medical Center, Edwards (United Kingdom), Beth Israel Deaconess Hospital, Ente Ospedaliero Ospedali Galliera, Minneapolis Heart Institute Foundation
- MSMartin S. Maron
Tufts Medical Center, Edwards (United Kingdom), Beth Israel Deaconess Hospital, Ente Ospedaliero Ospedali Galliera, Minneapolis Heart Institute Foundation
- AGAndrey G. Zenovich
Tufts Medical Center, Edwards (United Kingdom), Beth Israel Deaconess Hospital, Ente Ospedaliero Ospedali Galliera, Minneapolis Heart Institute Foundation
- FFFrancesco Formisano
Tufts Medical Center, Edwards (United Kingdom), Beth Israel Deaconess Hospital, Ente Ospedaliero Ospedali Galliera, Minneapolis Heart Institute Foundation
Topics & keywords
- Medicine
- Hypertrophic cardiomyopathy
- Cardiology
- Internal medicine
- Ventricular remodeling
- Stage (stratigraphy)
- Clinical significance
- Cardiomyopathy
- Good health and well-being